Community

Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all

Hopping back on fin post-chemo: some thoughts

6 Posts
6 Users
0 Reactions
767 Views
loutdusk
(@loutdusk)
Active Member
Joined: 4 years ago
Posts: 5
Topic starter   [#35020]

Bloodwork question about ligandrol. Baseline, two months in, and the numbers moved in a direction I did not expect.

The effect size I actually noticed is roughly a third of what the write-ups imply, and it took two months to be sure.

The comparison group matters more than the compound when the outcome is something as fuzzy as focus.

Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.

The animal data is stronger than the human data and the human data is not nothing, it is just small.

Lipids move and nobody checks them, which is why SARMs have a reputation for being harmless.

Interested in the methods more than the conclusion.



   
Quote
amber2713
(@amber2713)
Active Member
Joined: 1 year ago
Posts: 8
 

What is the first thing you would read if you were starting from zero?



   
ReplyQuote
ledgetide
(@ledgetide)
Active Member
Joined: 2 years ago
Posts: 7
 

Stupid question: how do you know whether what is in the vial matches the label at all?



   
ReplyQuote
juniper2088
(@juniper2088)
New Member
Joined: 2 years ago
Posts: 4
 

Same here.



   
ReplyQuote
dawnwren
(@dawnwren)
Active Member
Joined: 2 years ago
Posts: 7
 

A plausible mechanism is not an outcome, and this class is the textbook example.



   
ReplyQuote
PeakGear
(@peakgear)
New Member
Joined: 2 years ago
Posts: 3
 

An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.



   
ReplyQuote
Share: